#Pharmaceutical Industry
Explore articles tagged with Pharmaceutical Industry
Can Asset-Light Manufacturing Make Pharma Capacity Expansion Faster, More Flexible & Scalable? | Siliconindia
Hari Kiran Chereddi, Founder, MD & CEO, HRV Pharma, explores how asset-light manufacturing can help pharmaceutical companies build greater flexibility, scalability and efficiency into their manufacturing strategies.
India’s Race for the CDMO Crown | Express Pharma
HRV Pharma Founder, MD & CEO Hari Kiran Chereddi shares insights in Express Pharma on India’s opportunity to become a strategic global CDMO partner through specialised capabilities, regulatory strength, scientific expertise and reliable execution.
HRV Pharma Bets ₹150 Crore on Peptides & High-Potency Oncology APIs | Mint
HRV Pharma is investing around ₹150 crore in peptides and high-potency oncology APIs, expanding specialised manufacturing capabilities through an asset-light model and strategic manufacturing partnerships.
Why Pharma Needs Smarter Decision-Making, Not Just More Digital Systems
CEO Hari Kiran and CIO Sowjanya Varma in Express Pharma on why pharma’s next advantage lies in reasoning rather than more systems - and how RIKO™ shifts compliance from retrospective to predictive.
Building the Next Pipeline of Specialty APIs
HRV Pharma and Haleos Labs have entered into a multi-year strategic partnership to accelerate the development and GMP manufacturing of specialty APIs for regulated and semi-regulated markets.
Centre to Require Pharma to Distinguish Biologics from Synthetics | Mint
India’s proposed amendments to the Drugs Rules, 1945 could require pharmaceutical companies to clearly distinguish biological medicines from synthetic drugs, with implications for classification, traceability, quality and regulatory oversight.
India’s Pharma Industry Goes Digital
Digital transformation is reshaping pharmaceutical manufacturing in India, with technologies such as MES, electronic batch records, LIMS, digital twins, predictive analytics and AI helping strengthen compliance, data integrity and operational efficiency.
The New Growth Blueprint for APIs | BW Healthcare World
The API industry is rethinking how manufacturing capacity and supply chains are structured, with manufacturing networks offering a more resilient approach through qualified partners, regulatory ownership and greater visibility.
HRV Pharma Introduces RIKO™, India’s First AI-Native Pharmaceutical Operating System
RIKO™ is a self-learning reasoning engine built on seven years of proprietary pharmaceutical decisions across 50+ GMP-certified partners in 55 countries.
₹400+ Crore Pharma Business Without a Factory
Business Standard explores HRV Pharma’s asset-light model, which combines regulatory assets, drug master files and customer relationships with a network of 53 manufacturing partners to build pharmaceutical scale without owning manufacturing facilities.
Why the Future of Drug Development Begins Before Manufacturing
HRV Pharma CEO Hari Kiran Chereddi explains why drug development success is now determined before manufacturing, driven by data, predictive analytics, and strategic decision-making.
Future of Pharma: From Factories to Platform-Driven Models
HRV Pharma CEO Hari Kiran Chereddi shares insights on how platform-driven models are transforming pharma from factory-led systems to intelligent, network-based ecosystems.
From Supply Chain Risk to Supply Chain Advantage: How Indian CDMOs Are Reshaping Global Pharma
HRV Pharma MD & CEO Hari Kiran Chereddi shares insights on how Indian CDMOs are transforming global pharmaceutical supply chains from risk-driven models to resilient, flexible, and strategic advantage.
HRV Pharma Partners with Shodhana Laboratories to Accelerate Next-Gen API Development
HRV Pharma partners with Shodhana Laboratories to accelerate next-generation API development, combining AI-enabled virtual manufacturing with precision chemistry and global regulatory execution.
HRV Pharma Honoured at ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support
HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.
Why API Self-Reliance Is Back at the Centre of India’s Pharma Strategy
In BW Healthcare World, HRV Pharma MD & CEO Hari Kiran Chereddi outlines why API self-reliance has re-emerged as a strategic priority under Biopharma SHAKTI and what it means for India’s pharmaceutical future.
Union Budget 2026–27: Strengthening India’s Biopharma Ecosystem and Healthcare Access
HRV Pharma CEO Hari Kiran Chereddi shares his insights on how Union Budget 2026–27’s focus on biopharma innovation, affordable cancer care, and healthcare infrastructure will shape India’s pharmaceutical future.
How Virtual Manufacturing Is Solving Structural Causes of Global Drug Shortages
Virtual pharmaceutical manufacturing models are helping solve structural drug shortages by connecting global GMP capacity, improving supply flexibility, and strengthening regulatory execution.
HRV Pharma Partners with Haleos Labs to Accelerate Orphan and Niche API Development
HRV Pharma has entered a multi‑year strategic partnership with Haleos Labs to accelerate the development and manufacture of orphan and niche APIs, strengthening global access to complex therapies for rare diseases.
How HRV Pharma’s Virtual Model Helps Solve America’s Drug Shortage Crisis
HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.
HRV Pharma Redefines India’s Bulk Drug Business with a Virtual Pharma Model
Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.
Indian Biosimilars on the Global Stage: HRV Pharma CEO's Insights in Express Pharma
India's rise in biosimilars & biologics. Full clipping + insights included.
GLP-1 Patents Are Fading - Can India Become the GLP-1 Generics Powerhouse
As GLP-1 patents expire, India’s manufacturing scale, peptide chemistry expertise, and compliance readiness could position it to supply affordable GLP-1 generics globally — but consistency and supply reliability will decide who wins
HRV Pharma and Metrochem Strategic CDMO Alliance for High-Value NCE-1 APIs
HRV Pharma and Metrochem API Pvt. Ltd. have formed a multi-year CDMO alliance to accelerate high-value NCE-1 API development, combining Virtual Pharma innovation with world-class GMP chemistry
AI Is Redefining Pharma Forecasting and Eliminating the Compliance Trade-Off
Pharmaceutical Commerce features HRV Pharma on how AI-validated digital backbones speed regulatory reviews, improve supplier onboarding, and make forecasting more reliable.
Can AI Make Pharma Supply Chains Truly Unbreakable?
HRV Pharma's CEO discusses how AI transforms pharmaceutical supply chains from reactive systems to anticipatory networks, ensuring continuous medicine availability through predictive intelligence.
Rethinking Pharma Supply Chains: Building Resilience With Digital Intelligence
HRV Pharma's CEO Hari Kiran Chereddi explores how digital intelligence and AI are transforming pharmaceutical supply chains from efficiency-driven models to resilient, adaptive networks.
Building Resilient Pharmaceutical Supply Chains in an Era of Disruption
HRV Pharma's MD & CEO Hari Kiran Chereddi discusses strategic approaches to pharmaceutical supply chain resilience, highlighting multi-partner networks and AI-native operations for industry transformation.
From Pharmacy to Intelligent Pharmacy: AI's Role in India's Pharma Evolution
HRV Pharma's CEO Hari Kiran Chereddi discusses how AI is transforming India from the traditional "pharmacy of the world" into the "intelligent pharmacy of the world," revolutionizing drug discovery, regulatory processes, and supply chain management
From Volume to Value: India's Strategic API Leadership Evolution
HRV Global's Managing Director Hari Kiran Chereddi discusses India's transformation from volume-driven API supplier to value-oriented strategic partner, highlighting virtual pharma models and AI-driven operations.
US Tariffs Threaten Indian Pharma Exports-Urgent Need for Diversification and Policy Support
Our leadership analyzes impact of US 50% tariffs on Indian pharmaceutical exports, highlighting challenges for SMEs and strategic responses including market diversification.